[go: up one dir, main page]

Brown et al., 2004 - Google Patents

Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases

Brown et al., 2004

Document ID
6863384888297821217
Author
Brown D
Kozlowski H
Publication year
Publication venue
Dalton Transactions

External Links

Snippet

A change of the prion protein conformation results in a class of neurodegenerative diseases called the transmissible spongiform encephalopathies (like mad cow and Creutzfeld–Jakob diseases). The function of the normal prion protein is unknown, although much of recent …
Continue reading at pubs.rsc.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Similar Documents

Publication Publication Date Title
Brown et al. Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases
Atwood et al. Role of free radicals and metal ions in the pathogenesis of Alzheimer’s disease
Adlard et al. Metals and Alzheimer's disease
Gaeta et al. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
Roberts et al. The role of metallobiology and amyloid‐β peptides in Alzheimer’s disease
Bush Metals and neuroscience
Perry et al. Alzheimer disease and the role of free radicals in the pathogenesis of the disease
Cuajungco et al. Zinc takes the center stage: its paradoxical role in Alzheimer’s disease
Tabner et al. Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease
Sayre et al. Redox metals and neu rodegenerative disease
Rotilio et al. Copper‐dependent oxidative stress and neurodegeneration
Adlard et al. Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease
Singh et al. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease
WO1998040071A1 (en) Identification of agents for use in the treatment of alzheimer's disease
WO1998040071A9 (en) Identification of agents for use in the treatment of alzheimer's disease
Brown Brain proteins that mind metals: a neurodegenerative perspective
Keil et al. Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations
Deloncle et al. Is brain copper deficiency in Alzheimer's, Lewy body, and Creutzfeldt Jakob diseases the common key for a free radical mechanism and oxidative stress-induced damage?
Capanni et al. Investigation of the effects of copper ions on protein aggregation using a model system
Multhaup et al. Possible mechanisms of APP-mediated oxidative stress in Alzheimer’s disease
Kim et al. β-Sheet-breaking peptides inhibit the fibrillation of human α-synuclein
Inestrosa et al. Copper brain homeostasis: role of amyloid precursor protein and prion protein
US20050112543A1 (en) Method of screening for drugs useful in treating Alzheimer's disease
US7045531B1 (en) Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
Mendola et al. Prion proteins leading to neurodegeneration